Clinical Research Workshop, Part 1: What’s New in Cirrhosis Management—Shifting Paradigms and Implications for Clinical Research
Nov
2026
Description
This workshop highlights the evolving landscape of cirrhosis diagnosis and management, and explores how these changes are reshaping clinical research. Faculty challenge the traditional approaches to hepatocellular carcinoma (HCC) screening, and portal hypertension assessment and management. Presenters discuss the evolving concept of cirrhosis recompensation with a focus on implications for clinical trial design, end points, and patient stratification. Faculty provide a forward-looking view of cirrhosis research and address key research questions that need to be addressed in the near future. The workshop includes 3 breakout sessions where attendees have the opportunity to interact with experts in smaller groups to discuss clinical research topics of interest, including: (1) noninvasive tools for the management of portal hypertension; (2) recompensation in alcohol-associated liver disease; and (3) the future of HCC screening.
Presentations
2:00 PM
- 2:15 PM
Convention Center - Bluebird Ballroom 2ABC
What Is the Best Way to Screen for Hepatocellular Carcinoma in Your Patients? Biomarkers, Risk Stratification, and Other Nonimage-Based Methods
Tamar H Taddei, MD, MD, FAASLD | Presenter
2:15 PM
- 2:30 PM
Convention Center - Bluebird Ballroom 2ABC
Integrating New Baveno VIII Criteria Into Clinical Practice and Clinical Trial Design
Guadalupe Garcia-Tsao, MD, FAASLD | Presenter
2:30 PM
- 2:45 PM
Convention Center - Bluebird Ballroom 2ABC
Recompensation in Cirrhosis: Definitions, Evidence, Research Gaps, and Opportunities
Thomas Reiberger, MD | Presenter
2:45 PM
- 3:00 PM
Convention Center - Bluebird Ballroom 2ABC
Clinical Research in Cirrhosis in 2026 and Beyond: Key Questions, Data Platforms, and Team Science
Elliot B. Tapper, MD, FAASLD | Presenter